Last reviewed · How we verify

small amount of undiluted C3F8

Universidade Federal de Pernambuco · FDA-approved active Small molecule

C3F8 (perfluoropropane) is an expansile gas used in vitreoretinal surgery to provide internal tamponade and support retinal reattachment.

C3F8 (perfluoropropane) is an expansile gas used in vitreoretinal surgery to provide internal tamponade and support retinal reattachment. Used for Rhegmatogenous retinal detachment with superior breaks, Complex retinal detachment with proliferative vitreoretinopathy, Retinal detachment associated with macular hole.

At a glance

Generic namesmall amount of undiluted C3F8
SponsorUniversidade Federal de Pernambuco
Drug classPerfluorocarbon gas (surgical tamponade agent)
ModalitySmall molecule
Therapeutic areaOphthalmology
PhaseFDA-approved

Mechanism of action

C3F8 is a perfluorocarbon gas that expands to approximately 4 times its original volume over 6–8 weeks, creating a bubble that presses the detached retina back against the eye wall. This mechanical support allows the retinal pigment epithelium to reabsorb subretinal fluid and permits retinal breaks to heal. The gas is gradually absorbed and replaced by the eye's natural fluids.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: